Ka-Wai Cheung J, Li K, Zhou L, To C, Lam T
Int J Mol Sci. 2024; 25(19).
PMID: 39408973
PMC: 11476992.
DOI: 10.3390/ijms251910644.
Zhang J, Zhao J, Wang Q, Zhang R, Yue Y
Ann Lab Med. 2024; 44(6):507-517.
PMID: 38953114
PMC: 11375202.
DOI: 10.3343/alm.2023.0447.
Cho H, Lee J, Park K, Choi B, Lee M, Jeong D
Sci Rep. 2024; 14(1):14654.
PMID: 38918423
PMC: 11199617.
DOI: 10.1038/s41598-024-65616-x.
Liu K, Wu C, Zhu M, Xu J, Lin B, Lin H
Commun Biol. 2024; 7(1):505.
PMID: 38678117
PMC: 11055904.
DOI: 10.1038/s42003-024-06219-0.
Aggeletopoulou I, Kalafateli M, Triantos C
Int J Mol Sci. 2024; 25(5).
PMID: 38473878
PMC: 10932062.
DOI: 10.3390/ijms25052631.
High anti-tumor activity of a novel alpha-fetoprotein-maytansinoid conjugate targeting alpha-fetoprotein receptors in colorectal cancer xenograft model.
Griffin P, Hill W, Rossi F, Boohaker R, Stinson K, Sherman I
Cancer Cell Int. 2023; 23(1):60.
PMID: 37016369
PMC: 10074858.
DOI: 10.1186/s12935-023-02910-0.
Pathogenic and Potential Therapeutic Roles of Exosomes Derived From Immune Cells in Liver Diseases.
Zhou L, Shen M, Fan X, Liu Y, Yang L
Front Immunol. 2022; 13:810300.
PMID: 35185900
PMC: 8854144.
DOI: 10.3389/fimmu.2022.810300.
Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma.
Huang D, Liao M, Tong J, Yuan W, Peng D, Lai J
Aging (Albany NY). 2021; 13(22):24621-24639.
PMID: 34799469
PMC: 8660619.
DOI: 10.18632/aging.203698.
Potentiality of α-fetoprotein (AFP) and soluble intercellular adhesion molecule-1 (sICAM-1) in prognosis prediction and immunotherapy response for patients with hepatocellular carcinoma.
Cao W, Chen Y, Han W, Yuan J, Xie W, Liu K
Bioengineered. 2021; 12(2):9435-9451.
PMID: 34696675
PMC: 8809995.
DOI: 10.1080/21655979.2021.1990195.
Immunotherapy Updates in Advanced Hepatocellular Carcinoma.
Singh A, Beechinor R, Huynh J, Li D, Dayyani F, Valerin J
Cancers (Basel). 2021; 13(9).
PMID: 33946408
PMC: 8125389.
DOI: 10.3390/cancers13092164.
Recent updates on chimeric antigen receptor T cell therapy for hepatocellular carcinoma.
Guo J, Tang Q
Cancer Gene Ther. 2021; 28(10-11):1075-1087.
PMID: 33500535
DOI: 10.1038/s41417-020-00259-4.
AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway.
Chen T, Dai X, Dai J, Ding C, Zhang Z, Lin Z
Cell Death Dis. 2020; 11(10):822.
PMID: 33009373
PMC: 7532541.
DOI: 10.1038/s41419-020-03030-7.
Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection.
Rungsakulkij N, Suragul W, Mingphruedhi S, Tangtawee P, Muangkaew P, Aeesoa S
World J Clin Cases. 2018; 6(6):110-120.
PMID: 29988930
PMC: 6033749.
DOI: 10.12998/wjcc.v6.i6.110.
Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection.
Rungsakulkij N, Suragul W, Mingphruedhi S, Tangtawee P, Muangkaew P, Aeesoa S
Infect Agent Cancer. 2018; 13:20.
PMID: 29930697
PMC: 5994073.
DOI: 10.1186/s13027-018-0192-7.
Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng-Tongji cohort study.
Wang K, Bai Y, Chen S, Huang J, Yuan J, Chen W
Cancer Med. 2018; 7(6):2691-2698.
PMID: 29696820
PMC: 6010894.
DOI: 10.1002/cam4.1481.
Inhibitory effect of MyoD on the proliferation of breast cancer cells.
Cai C, Qin X, Wu Z, Shen Q, Yang W, Zhang S
Oncol Lett. 2016; 11(6):3589-3596.
PMID: 27284360
PMC: 4887810.
DOI: 10.3892/ol.2016.4448.
An update of biochemical markers of hepatocellular carcinoma.
Alsalloom A
Int J Health Sci (Qassim). 2016; 10(1):121-36.
PMID: 27004063
PMC: 4791163.
Non-Invasive Screening Tools for Down's Syndrome: A Review.
Sillence K, Madgett T, Roberts L, Overton T, Avent N
Diagnostics (Basel). 2016; 3(2):291-314.
PMID: 26835682
PMC: 4665531.
DOI: 10.3390/diagnostics3020291.
2D DIGE proteomic analysis highlights delayed postnatal repression of α-fetoprotein expression in homocystinuria model mice.
Kamata S, Akahoshi N, Ishii I
FEBS Open Bio. 2015; 5:535-41.
PMID: 26199862
PMC: 4506956.
DOI: 10.1016/j.fob.2015.06.008.
Molecular Analysis of AFP and HSA Interactions with PTEN Protein.
Zhu M, Lin B, Zhou P, Li M
Biomed Res Int. 2015; 2015:256916.
PMID: 26078940
PMC: 4452835.
DOI: 10.1155/2015/256916.